List of works by Arzu Didem Yalcin

270 Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy.

scientific article published on 17 February 2012

278 Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations in Patients With Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment.

scientific article published on 17 February 2012

305 Incidence of Allergy in Patients With Benign Lesions of the Vocal Cords: Preliminary Report.

scientific article published on 17 February 2012

426 The Evaluation of Allergen Sensitivity in Food Allergy Patients in Antalya, Turkey.

scientific article published on 17 February 2012

481 Differences in Humoral and Cellular Immunity in Young and Old Individuals.

scientific article published on 17 February 2012

A case of toxic epidermal necrolysis with diverse etiologies: successful treatment with intravenous immunoglobulin and pulse prednisolone and effects on sTRAIL and sCD200 levels

scientific article published in January 2013

Advances in anti-IgE therapy

scientific article published on 5 May 2015

Allergic diseases of the skin and drug allergies – 2027. Successful treatment with intravenous immunoglobulin and prednisolone pulse therapy of toxic epidemal necrolysis and Stevens-Johnson Syndrome.

scientific article

An overview of the effects of anti-IgE therapies

scientific article published on 22 September 2014

Association of circulating sTRAIL and high-sensitivity CRP with type 2 diabetic nephropathy and foot ulcers

scientific article published on 29 August 2013

Basic and clinical immunology – 3031. The correlation between serum protemics patterns of sTRAIL and CXCL8 with FDG-PET/CT findings in bevacizumab treated colon cancers

Basic and clinical immunology – 3032. 18FDG-PET/CT findings (SUV-MAX) are correlated with survival in stage-4 squamous cell carcinoma

scientific article

CD40, CD45 CTLA-4 levels are elevated in healthy older adults.

scientific article published in January 2012

CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients

scientific article published on 30 June 2016

Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment.

scientific article published on December 2014

Circulating apo 2L levels decreased in hepatitis C with the pegilated interferon-2 alpha treatment.

scientific article

Circulating soluble apo 2L, soluble OX-2: a possible screening biomarker for stage-4 ovarian, endometrial CA. ⬇️

scientific article published on 8 April 2015

Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma.

scientific article

Common variable immunodeficiency syndrome with right aortic arch: a case report

scientific article

D-dimer levels decreased in severe allergic asthma and chronic urticaria patients with the omalizumab treatment

scientific article published on 23 December 2013

Effects of omalizumab on eosinophil cationic peptide, 25-hydroxyvitamin-D, IL-1β and sCD200 in cases of Samter's syndrome: 36 months follow-up

scientific article published on 10 July 2013

Environmental and occupational respiratory diseases – 1039. Clinical course and side effects of anti-IgE monoclonal antibody in patients with severe persistent asthma

scientific article published in April 2013

Environmental and occupational respiratory diseases – 1062. The climate and aero allergens in Mediterranean region and allergen sensitivity in allergic rhinoconjuctivitis and allergic asthma patients

Erratum to "IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer" [Clin. Lab. 2012; 58:501-505].

scientific article published in January 2012

Erratum: Circulating Apo 2L levels decreased in genotype II hepatitis C with pegylated interferon-2 alpha treatment.

scientific article

Evaluation of d-dimer, CXCL8, homocysteine, eosinophil cationic peptide, 25(OH)-vitamin D and immunomodulatory OX-2 levels in allergic patients.

scientific article published on 13 January 2015

Evaluation of sOX-2 levels in type2 diabetic foot and nephropathic patients: association with disease activity

Evaluation of soluble CD200 levels in type 2 diabetic foot and nephropathic patients: association with disease activity

scientific article

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients.

scientific article published on 23 April 2013

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment

scientific article

High serum soluble CD200 levels in patients with autosomal dominant polycystic kidney disease

scientific article published on 8 February 2017

IL-8, IL-10, TGF-β, and GCSF levels were increased in severe persistent allergic asthma patients with the anti-IgE treatment

scientific article published on 19 December 2012

IL8 and serum soluble TRAIL levels following anti-VEGF monoclonal antibody treatment in patients with metastatic colon cancer

scientific article published in January 2012

Immunotherapy – 2071. Strail levels decreased after allergen-subcutaneous specific immunotherapy

Increased serum S-TRAIL level in newly diagnosed stage-IV lung adenocarcinoma but not squamous cell carcinoma is correlated with age and smoking

scientific article published in January 2013

Increased serum sTRAIL levels were correlated with survival in bevacizumab-treated metastatic colon cancer

scientific article

Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers

scientific article published on 21 October 2013

Levofloxacin Induced Toxic Epidermal Necrolysis: Successful Therapy with Omalizumab (Anti-IgE) and Pulse Prednisolone

scientific article published on 16 September 2016

Mechanisims of asthma and allergic disease - 1088. Increased serum strail level in newly diagnosed stave-iv lung adenocarcinoma but not sqamous cell carcinoma, is correlated with age and smoking.

scientific article

Mechanisims of asthma and allergic disease – 1066. Ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis

scientific article published on 23 April 2013

Montelukast is as effective as penicillin in treatment of acute otitis media: an experimental rat study

scientific article published on 19 September 2013

Omalizumab (anti-IgE) therapy in the asthma-COPD overlap syndrome (ACOS) and its effects on circulating cytokine levels

scientific article published on 28 April 2016

Omalizumab (anti-IgE) therapy increases blood glucose levels in severe persistent allergic asthma patients with diabetes mellitus: 18 month follow-up.

scientific article published in January 2014

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor

scientific article published on 8 April 2015

Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1β levels

scientific article published on 24 July 2013

Perioperative antibiotic prophylaxis and cost in a Turkish University Hospital

scientific article

Pollen aero allergens and the climate in Mediterranean region and allergen sensitivity in allergic rhinoconjunctivitis and allergic asthma patients

scientific article published on 11 February 2013

Proteomics pattern of peritoneal sApo-2L but not CD200 (OX-2) as a possible screening biomarker for metastatic ovarian, endometrial and breast carcinoma

scientific article

Serum-soluble TRAIL levels in patients with severe persistent allergic asthma: its relation to omalizumab treatment

scientific article published on March 2012

Soluble TRAIL levels decreased in chronic hepatitis C treatment with pegylated interferon α plus ribavirin: association with viral responses

scientific article published on 15 December 2014

Soluble trail as a marker of efficacy of allergen-specific immunotherapy in patients with allergic rhinoconjunctivitis

scientific article published on October 2012

Systemic levels of ceruloplasmin oxidase activity in allergic asthma and allergic rhinitis

scientific article published on 28 June 2012

The effects of climate and aero allergens changes in allergic rhinoconjunctivitis and allergic asthma patients in Mediterranean region between 2011 and 2012.

scientific article published on 28 August 2013

The relation of sTRAIL levels and quality of life in severe persistent allergic asthma patients using omalizumab.

scientific article published in August 2012

There might be a role for CD200 in the pathogenesis of autoimmune and inflammatory skin disorders

scientific article published on 25 October 2013

Total antioxidant capacity, hydrogen peroxide, malondialdehyde and total nitric oxide concentrations in patients with severe persistent allergic asthma: its relation to omalizumab treatment.

scientific article published in January 2012

Trimetazidine effect on burn-induced intestinal mucosal injury and kidney damage in rats

scientific article

Vitamin D serum levels in allergic rhinitis

scholarly article by Sukran Kose et al published 8 April 2015 in The World Allergy Organization Journal

XXIV World Allergy Congress 2015

scientific article (publication date: April 2016)

Paulina is supported by:

About Paulina

Help